126 related articles for article (PubMed ID: 29236321)
1. Murine models of osteosarcoma: A piece of the translational puzzle.
Walia MK; Castillo-Tandazo W; Mutsaers AJ; Martin TJ; Walkley CR
J Cell Biochem; 2018 Jun; 119(6):4241-4250. PubMed ID: 29236321
[TBL] [Abstract][Full Text] [Related]
2. Activation of PTHrP-cAMP-CREB1 signaling following p53 loss is essential for osteosarcoma initiation and maintenance.
Walia MK; Ho PM; Taylor S; Ng AJ; Gupte A; Chalk AM; Zannettino AC; Martin TJ; Walkley CR
Elife; 2016 Apr; 5():. PubMed ID: 27070462
[TBL] [Abstract][Full Text] [Related]
3. Molecular pathogenesis of osteosarcoma.
Kansara M; Thomas DM
DNA Cell Biol; 2007 Jan; 26(1):1-18. PubMed ID: 17263592
[TBL] [Abstract][Full Text] [Related]
4. Bone environment is essential for osteosarcoma development from transformed mesenchymal stem cells.
Rubio R; Abarrategi A; Garcia-Castro J; Martinez-Cruzado L; Suarez C; Tornin J; Santos L; Astudillo A; Colmenero I; Mulero F; Rosu-Myles M; Menendez P; Rodriguez R
Stem Cells; 2014 May; 32(5):1136-48. PubMed ID: 24446210
[TBL] [Abstract][Full Text] [Related]
5. RANKL blockade prevents and treats aggressive osteosarcomas.
Chen Y; Di Grappa MA; Molyneux SD; McKee TD; Waterhouse P; Penninger JM; Khokha R
Sci Transl Med; 2015 Dec; 7(317):317ra197. PubMed ID: 26659571
[TBL] [Abstract][Full Text] [Related]
6. Conditional mouse osteosarcoma, dependent on p53 loss and potentiated by loss of Rb, mimics the human disease.
Walkley CR; Qudsi R; Sankaran VG; Perry JA; Gostissa M; Roth SI; Rodda SJ; Snay E; Dunning P; Fahey FH; Alt FW; McMahon AP; Orkin SH
Genes Dev; 2008 Jun; 22(12):1662-76. PubMed ID: 18559481
[TBL] [Abstract][Full Text] [Related]
7. Osteosarcoma in the Post Genome Era: Preclinical Models and Approaches to Identify Tractable Therapeutic Targets.
Castillo-Tandazo W; Mutsaers AJ; Walkley CR
Curr Osteoporos Rep; 2019 Oct; 17(5):343-352. PubMed ID: 31529263
[TBL] [Abstract][Full Text] [Related]
8. Proteomics of osteosarcoma.
Bernardini G; Laschi M; Geminiani M; Santucci A
Expert Rev Proteomics; 2014 Jun; 11(3):331-43. PubMed ID: 24654989
[TBL] [Abstract][Full Text] [Related]
9. Molecular analysis of p53, MDM2, and H-ras genes in osteosarcoma and malignant fibrous histiocytoma of bone in patients older than 40 years.
Kawaguchi K; Oda Y; Sakamoto A; Saito T; Tamiya S; Iwamoto Y; Tsuneyoshi M
Mod Pathol; 2002 Aug; 15(8):878-88. PubMed ID: 12181274
[TBL] [Abstract][Full Text] [Related]
10. Secreted Frizzled-Related Protein 2 (sFRP2) promotes osteosarcoma invasion and metastatic potential.
Techavichit P; Gao Y; Kurenbekova L; Shuck R; Donehower LA; Yustein JT
BMC Cancer; 2016 Nov; 16(1):869. PubMed ID: 27821163
[TBL] [Abstract][Full Text] [Related]
11. Optimization of the chicken chorioallantoic membrane assay as reliable in vivo model for the analysis of osteosarcoma.
Kunz P; Schenker A; Sähr H; Lehner B; Fellenberg J
PLoS One; 2019; 14(4):e0215312. PubMed ID: 30986223
[TBL] [Abstract][Full Text] [Related]
12. mTORC1 maintains the tumorigenicity of SSEA-4(+) high-grade osteosarcoma.
Zhang W; Ding ML; Zhang JN; Qiu JR; Shen YH; Ding XY; Deng LF; Zhang WB; Zhu J
Sci Rep; 2015 Apr; 5():9604. PubMed ID: 25853231
[TBL] [Abstract][Full Text] [Related]
13. The Protein Tyrosine Phosphatase Rptpζ Suppresses Osteosarcoma Development in Trp53-Heterozygous Mice.
Baldauf C; Jeschke A; Kanbach V; Catala-Lehnen P; Baumhoer D; Gerull H; Buhs S; Amling M; Nollau P; Harroch S; Schinke T
PLoS One; 2015; 10(9):e0137745. PubMed ID: 26360410
[TBL] [Abstract][Full Text] [Related]
14. Genetically engineered mouse models and human osteosarcoma.
Ng AJ; Mutsaers AJ; Baker EK; Walkley CR
Clin Sarcoma Res; 2012 Oct; 2(1):19. PubMed ID: 23036272
[TBL] [Abstract][Full Text] [Related]
15. Modeling human osteosarcoma in mice through 3AB-OS cancer stem cell xenografts.
Di Fiore R; Guercio A; Puleio R; Di Marco P; Drago-Ferrante R; D'Anneo A; De Blasio A; Carlisi D; Di Bella S; Pentimalli F; Forte IM; Giordano A; Tesoriere G; Vento R
J Cell Biochem; 2012 Nov; 113(11):3380-92. PubMed ID: 22688921
[TBL] [Abstract][Full Text] [Related]
16. The DNA helicase recql4 is required for normal osteoblast expansion and osteosarcoma formation.
Ng AJ; Walia MK; Smeets MF; Mutsaers AJ; Sims NA; Purton LE; Walsh NC; Martin TJ; Walkley CR
PLoS Genet; 2015 Apr; 11(4):e1005160. PubMed ID: 25859855
[TBL] [Abstract][Full Text] [Related]
17. MiR-9 is overexpressed in spontaneous canine osteosarcoma and promotes a metastatic phenotype including invasion and migration in osteoblasts and osteosarcoma cell lines.
Fenger JM; Roberts RD; Iwenofu OH; Bear MD; Zhang X; Couto JI; Modiano JF; Kisseberth WC; London CA
BMC Cancer; 2016 Oct; 16(1):784. PubMed ID: 27724924
[TBL] [Abstract][Full Text] [Related]
18. Genetic and molecular characterization of the human osteosarcoma 3AB-OS cancer stem cell line: a possible model for studying osteosarcoma origin and stemness.
Di Fiore R; Fanale D; Drago-Ferrante R; Chiaradonna F; Giuliano M; De Blasio A; Amodeo V; Corsini LR; Bazan V; Tesoriere G; Vento R; Russo A
J Cell Physiol; 2013 Jun; 228(6):1189-201. PubMed ID: 23129384
[TBL] [Abstract][Full Text] [Related]
19. miR-27a and miR-27a* contribute to metastatic properties of osteosarcoma cells.
Salah Z; Arafeh R; Maximov V; Galasso M; Khawaled S; Abou-Sharieha S; Volinia S; Jones KB; Croce CM; Aqeilan RI
Oncotarget; 2015 Mar; 6(7):4920-35. PubMed ID: 25749032
[TBL] [Abstract][Full Text] [Related]
20. RASSF5 inhibits growth and invasion and induces apoptosis in osteosarcoma cells through activation of MST1/LATS1 signaling.
Zhou XH; Yang CQ; Zhang CL; Gao Y; Yuan HB; Wang C
Oncol Rep; 2014 Oct; 32(4):1505-12. PubMed ID: 25109282
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
